Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model

Licun Wu; Matthew Onn Wu; Luis De la Maza; Zhihong Yun; Julie Yu; Yidan Zhao; John Cho; Marc de Perrot

doi:10.18632/oncotarget.3487

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model

Licun Wu, Matthew Onn Wu, Luis De la Maza, Zhihong Yun, Julie Yu, Yidan Zhao, John Cho and Marc de Perrot _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:12468-12480. https://doi.org/10.18632/oncotarget.3487

Metrics: PDF 2637 views | HTML 3017 views | ?

Abstract

Licun Wu1, Matthew Onn Wu1, Luis De la Maza1, Zhihong Yun1, Julie Yu1, Yidan Zhao1, John Cho2 and Marc de Perrot1

1 Latner Thoracic Surgery Research Laboratories and Division of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada

2 Radiation Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, ON, Canada

Correspondence to:

Marc de Perrot, email:

Keywords: mesothelioma, local radiotherapy, abscopal effect, immune checkpoint

Received: November 24, 2014 Accepted: February 03, 2015 Published: March 08, 2015

Abstract

We previously demonstrated that blockade of immune suppressive CTLA-4 resulted in tumor growth delay when combined with chemotherapy in murine mesothelioma. Tumor-infiltrating T cells (TIT) after local radiotherapy (LRT) play critical roles in abscopal effect against cancer. We attempt to improve the local and abscopal effect by modulating T cell immunity with systemic blockade of CTLA-4 signal.The growth of primary tumors was significantly inhibited by LRT while CTLA-4 antibody enhanced the antitumor effect. Growth delay of the second tumors was achieved when the primary tumor was radiated. LRT resulted in more T cell infiltration into both tumors, including Treg and cytotoxic T cells. Interestingly, the proportion of Treg over effector T cells in both tumors was reversed after CTLA-4 blockade, while CD8 T cells were further activated. The expression of the immune-related genes was upregulated and cytokine production was significantly increased. LRT resulted in an increase of TIT, while CTLA-4 blockade led to significant reduction of Tregs and increase of cytotoxic T cells in both tumors. The abscopal effect is enhanced by targeting the immune checkpoints through modulation of T cell immune response in murine mesothelioma.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 3487

Publication Alerts

Research Papers:

Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model

Abstract